GLP-1 Agonist Therapy Center

New combination drug has better efficacy in glucose control and weight loss than when taken separately.

First oral GLP-1 agonist undergoing Phase 3 trials shows significant benefits managing type 2 diabetes.

Study looks at convenient once-weekly GLP-1 that can reduce chances of heart attacks and strokes.

This GLP-1 Agonist Medications Chart outlines the latest GLP-1 medications approved by the FDA for diabetes treatment and the differences and similarities between them. Print out this chart and post in your office as a handy reference for your staff and patients alike. The chart is in PDF format. Use this link to download: GLP-1 Agonist Medications Chart

Researchers study efficacy and safety of GLP-1 inhibitors on weight loss.

When combined with diet and exercise, GLP-1 medication showed significant weight loss compared to liraglutide and placebo, a new study finds.

New findings compare treatment with patients taking two or more glucose-lowering agents.

Investigators find patients treated with GLP-1 drug had significantly lower number of amputations compared to placebo group.

Key ADA poster summaries include liraglutide in type 1 diabetes, oral semaglutide, bottled water's association with type 2 diabetes, & SGLT-2 combo LIK066.

GLP-1 agonists randomized showdown. Which agent is better?